Systematic Use of Telepsychiatry for Outpatients
1 other identifier
interventional
34
1 country
1
Brief Summary
Implementation and evaluation of video consultation in psychiatric outpatient treatment. The study will focus on patients' experiences regarding the use of VC. The study will also examine important aspects of the telepsychiatric consultation such as therapeutic alliance, consultation content, psychopathology and satisfaction levels compared to face-to-face consultations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 26, 2022
CompletedFirst Submitted
Initial submission to the registry
May 10, 2022
CompletedFirst Posted
Study publicly available on registry
August 25, 2022
CompletedMarch 31, 2023
March 1, 2023
1 year
May 10, 2022
March 28, 2023
Conditions
Outcome Measures
Primary Outcomes (9)
The demand for video consultation (VC) in clinical practice.
The demand for VC is evaluated by the percentage of included participants who chose to be in the VC group and the actual use of VC consultation sessions during the study period, including the number of missed appointments and the number of times VC sessions have been converted to telephone or in-person (IP) consultations.
One year
Patients' therapeutic alliance, assessed by working alliance inventory- client version (WAI-C)
Therapeutic alliance is evaluated with the mean change scores in the WAI-C questionnaire at baseline and posttreatment. Score ranging: from 12 to 84. Higher scores indicate a higher therapeutic alliance
Two months.
Patients' satisfaction, assessed by client satisfaction questionnaire 8 (CSQ-8)
Satisfaction is evaluated with the mean change scores in the CSQ-8 questionnaire at baseline and posttreatment. Score ranging: from 8 to 32. Higher scores indicate a higher satisfaction
Two months.
Patients' Symptom level, assessed by Symptom Checklist -10 (SCL-10)
Symptom level is evaluated with the mean change scores in the SCL-10 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Lower score indicates lower psychological distress
Two months.
Patients' well-being, assessed by World Health Organisation- Five Well-Being Index (WHO-5)
Well-being level is evaluated with the mean change scores in the WHO-5 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Higher scores indicate higher well-being
Two months.
Patients' function, assessed by Sheehan Disability Scale (SDS)
Functional impairment is evaluated with the mean change scores in the SDS questionnaire at baseline and posttreatment. Score ranging: from 0 to 30. lower scores indicate lower functional impairment
Two months.
Patient recovery, assessed by INSPIRE
Patient recovery is evaluated with the mean change scores in the INSPIRE questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. A higher score indicates higher recovery
Two months.
The implementation and integration of VC in clinical practice, as assessed by a checklist developed for the case managers (CM).
The following properties are used to evaluate the implementation and integration properties: 1. type of technology patients use for VC sessions (Smartphone/tablet or personal computer/laptop) 2. patients' physical location during VC session (Home or outdoor) 3. the VC sessions confidentiality (Alone or with other persons) 4. duration of VC session 5. the content of the VC sessions (supportive, therapy, medication management, crisis/acute or "mix" content) Descriptive statistics will be applied to evaluate the implementation and integration properties.
One year
Patients' experiences regarding the use of VC
Semistructured interviews have been conducted to evaluate participants' experience regarding the use of VC technology in clinical practice.
Two months
Study Arms (2)
Video group
EXPERIMENTALCase management through video format
In-person
ACTIVE COMPARATORCase management through in person format
Interventions
Case management cover therapy (psychotherapy/psychoeducation), medication adjustment, training in daily living skills (supportive), and direct consultations in crises.
Eligibility Criteria
You may qualify if:
- age \> 18 years
- Danish-speaking.
You may not qualify if:
- Additionally, Participants in the VC group were excluded if they did not have a smartphone, tablet, laptop, or personal computer with a webcam.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Psychiatric research unit, Region Zealand,
Slagelse, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2022
First Posted
August 25, 2022
Study Start
April 21, 2021
Primary Completion
April 26, 2022
Study Completion
April 26, 2022
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share